Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

DOJ Step-by-Step Guidance to Determine if Trade Secrets are Confidential Under the Freedom of Information Act (FOIA)

By John Arszulowicz & Astor Heaven on July 29, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

On October 7, 2019, the U.S. Department of Justice (“DOJ”) issued a Step-by-Step Guide for Determining if Commercial or Financial Information Obtained from a Person is Confidential Under Exemption 4 of the FOIA. The Step-by-Step Guide is used by agencies, in conjunction with guidance from the Office of Information Policy (“OIP”) to determine whether commercial or financial information provided by a person is “confidential” under FOIA Exemption 4. FOIA Exemption 4 protects trade secrets and commercial information that is privileged or confidential. The DOJ Guidance is another tool that can be used by practitioners to determine when information must be disclosed under a FOIA Request.

The DOJ Guidance followed on the heels of the Supreme Court’s decision in in Food Marketing Institute v. Argus Leader Media (described in a previous blog post) where the Supreme Court addressed the question of “when does information provided to a federal agency qualify as confidential.” The Supreme Court held that information is confidential and protected if: (1) the information is “customarily kept private, or at least closely held” and (2) where the receiving party provides “some assurance” that the information will be kept secret.

The DOJ Guidance outlines three questions to help determine if information is confidential under FOIA Exemption 4.

  1. Does the submitter customarily keep the information private or closely-held? (This inquiry may in appropriate contexts be determined from industry practices concerning the information.
    • If no, the information is not confidential under Exemption 4.
    • If yes, answer question 2.
  2. Did the government provide an express or implied assurance of confidentiality when the information was shared with the government?
    • If no, answer question 3.
    • If yes, the information is confidential under Exemption 4 (this is the situation that was present in Argus Leader).
  3. Were there express or implied indications at the time the information was submitted that the government would publicly disclose the information?
    • If no, the information is “confidential” under Exemption 4 (the government has effectively been silent – it hasn’t indicated the information would be protected or disclosed – so a submitter’s practice of keeping the information private will be sufficient to warrant confidential status).
    • If yes and no other sufficient countervailing factors exist, the submitter could not reasonably expect confidentiality upon submission and so the information is not confidential under Exemption 4.

FOIA Request responses remain tricky to navigate especially when trade secret information is involved. Although short, the DOJ Guidance provides yet another tool to assist practitioners in navigating the pitfalls of FOIA Requests.

Photo of John Arszulowicz John Arszulowicz

John Arszulowicz is an associate in Crowell & Moring’s Washington, D.C. office and a member of the Tax and International Trade groups. John’s practice focuses on advising clients on tax controversy, tax planning, trade remedies, and import regulatory compliance matters. John also supports…

John Arszulowicz is an associate in Crowell & Moring’s Washington, D.C. office and a member of the Tax and International Trade groups. John’s practice focuses on advising clients on tax controversy, tax planning, trade remedies, and import regulatory compliance matters. John also supports the firm’s Corporate Group on asset-based and real estate loans and loan restructures. In addition, John supports the firm’s U.S. Food and Drug Administration (FDA) matters. John’s experience includes researching and summarizing numerous compliance and liability concerns for the distribution and labeling of FDA-regulated products granted an Emergency Use Authorization or enforcement discretion exception during the nation’s COVID-19 response. Prior to joining Crowell & Moring, John was a credentialed agency official at the FDA, where he completed the FDA’s basic food and drug law course. John was also a summer intern at the U.S. Department of Labor, Office of the Solicitor. During this summer internship, John was involved in a variety of Employee Retirement Income Security Act of 1974 (ERISA) matters. John was selected as a Gary S. Tell ERISA Litigation Scholar.

Read more about John ArszulowiczEmail
Show more Show less
Photo of Astor Heaven Astor Heaven
Read more about Astor HeavenEmail
  • Posted in:
    Administrative and Regulatory
  • Blog:
    Trade Secrets Trends
  • Organization:
    Crowell & Moring LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo